Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,726 public trials 634 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Active, Not Recruiting

A Study Evaluating TRIV-509 in Atopic Dermatitis

NCT07167758

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Triveni Bio Site #11 Fountain Valley, California, United States
  • Triveni Bio Site #4 San Diego, California, United States
  • Triveni Bio Site #3 Miami, Florida, United States
  • Triveni Bio Site #6 Indianapolis, Indiana, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

NCT03952559

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Instituto de Neumonología Y Dermatología Capital Federal, Buenos Aires, Argentina
  • Centro de Investigaciones Metabólicas (CINME) Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • Fundacion CIDEA Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina
  • Fundación Respirar Buenos Aires, Argentina
View all 78 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

NCT06025578

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +23 more
Locations
  • Local Institution - 0046 Birmingham, Alabama, United States
  • Local Institution - 0314 Phoenix, Arizona, United States
  • Local Institution - 0336 La Jolla, California, United States
  • Local Institution - 0212 Los Angeles, California, United States
View all 459 locations
View Trial Details
Active, Not Recruiting

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT05769777

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Allervie Clinical Research - Birmingham- Site Number : 8400050 Birmingham, Alabama, United States
  • Research Solutions of Arizona- Site Number : 8400020 Litchfield Park, Arizona, United States
  • Dermatology Trial Associates- Site Number : 8400027 Bryant, Arkansas, United States
  • University Dermatology Trials- Site Number : 8400052 Newport Beach, California, United States
View all 174 locations
View Trial Details
Active, Not Recruiting

A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

NCT06526182

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Hospital General Universitario Dr. Balmis Alicante, Spain
  • Hospital del Mar - Parc de Salut Mar Barcelona, Spain
  • Hospital Universitario Clínico San Cecilio Granada, Spain
  • Consorci Hospital General Universitari de València Valencia, Spain
View Trial Details
Active, Not Recruiting

To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

NCT06552520

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Tongling People's Hospital Tongling, Anhui, China
  • The Second Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 73 locations
View Trial Details

Related conditions